Childhood cancers trials in Germany

In Germany 144 Also abroad 2483

144 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Impact of Thyroid Hormones on Human Glucose and Energy Metabolism
Where
Ulm
People
60
Run by
University of Ulm
See details and how to joinNCT07410637
Phase 1/2Taking people
Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
Where
Berlin, Duesseldorf, Essen, Frankfurt Am Main, Freiburg, Hamburg, Hannover, Kiel, München, Tuebingen, Ulm, Wuerzburg
Age
3 years to 18 years
People
20
Run by
University Hospital Tuebingen
See details and how to joinNCT05366218 · EU 2024-511336-28-00
No phaseTaking people
CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer
Where
Augsburg, Berlin, Cologne, Dresden, Erlangen, Essen, Heidelberg, Regensburg, Stuttgart, Tübingen, Ulm, Würzburg
Age
14 years to 100 years
People
5,000
Run by
German Cancer Research Center
See details and how to joinNCT05652569
No phaseTaking people
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Where
Essen
People
50 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06357754
Phase 1/2Taking people
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Where
Augsburg, Berlin, Essen, Greifswald, Hamburg, Köln, Mainz, München, Münster, Regensburg, Tübingen
Age
1 year to 64 years
People
160 worldwide
Run by
University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00
No phaseTaking people
Risk Factors for Neuroendocrine Neoplasms
Where
Nuremberg
People
14,250
Run by
Bavarian Cancer Registry
See details and how to joinNCT06282016
No phaseTaking people
Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
Where
Erlangen
Age
3 years to 17 years
People
30
Run by
University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07313878
No phaseTaking people
Medulloblastoma Online Video-based Exercise Pilot Study
Where
München
Age
3 years to 18 years
People
15 worldwide
Run by
Aron Onerup
See details and how to joinNCT06898684
No phaseNot yet taking people in Germany
A Comprehensive, Multinational GIST Registry
Where
Essen
People
1,000
Run by
Universität Duisburg-Essen
See details and how to joinNCT07273045
Phase 1/2Taking people
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Where
Augsburg, Berlin, Cologne, Essen, Frankfurt Am Main, Hamburg, Muenster
Age
1 year to 25 years
People
65 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT04925609 · EU 2024-513412-10-00
No phaseTaking people
International HIT-MED Registry (I-HIT-MED)
Where
Aachen, Augsburg, Berlin, Bielefeld, Braunschweig, Bremen, Chemnitz, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duisburg, Düsseldorf, Erfurt, Erlangen, Essen, Frankfurt, Freiburg im Breisgau, Giessen, Göttingen, Greifswald, Halle, Hamburg, Hanover, Heidelberg, Heilbronn, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Leipzig, Lübeck, Magdeburg, Mainz, Mannheim, Minden, München, Münster, Nuremberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tübingen, Ulm, Wiesbaden, Wolfsburg, Würzburg
People
500
Run by
Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT02417324
Phase 1Taking people
VyClo ITCC-092
Where
Augsburg, Berlin, Essen, Frankfurt Am Main, Hamburg
Age
Up to 64 years
People
25 worldwide
Run by
Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-508050-26-00
Phase 1/2Taking people
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Where
Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00
Phase 1/2Taking people
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01
Phase 1/2Taking people
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00
No phaseTaking people
Liquid Biopsy Under PSMA Radioligand Therapy
Where
Augsburg, München, Würzburg
People
100
Run by
Wuerzburg University Hospital
See details and how to joinNCT07118436
Phase 1Taking people
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Where
Berlin, Cologne, Greifswald, Tuebingen
Age
18 months to 18 years
People
38 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00
Phase 3Taking people
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Where
Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Dortmund, Dresden, Düsseldorf, Erfurt, Erlangen, Essen, Frankfurt, Giessen, Göttingen, Greifswald, Halle Saale, Hamburg, Hanover, Heidelberg, Homburg, Jena, Karlsruhe, Kassel, Kiel, Köln, Krefeld, Leipzig, Luebeck, Magdeburg, Mainz, München, Münster, Regensburg, Rostock, Stuttgart, Tübingen, Ulm, Würzburg, UNIVERSITÄTSKLINIKUM FREIBURG
Age
Up to 21 years
People
800 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00
No phaseTaking people
International Rare Histiocytic Disorders Registry (IRHDR)
Where
Rostock
People
400 worldwide
Run by
The Hospital for Sick Children
See details and how to joinNCT02285582
No phaseEnrolling by invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
Where
Hanover, Munich, Tübingen
Age
1 day and over
People
500 worldwide
Run by
Prof. Valérie Mc Lin
See details and how to joinNCT06041906
Phase 1/2Taking people
CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
Where
Tübingen
Age
8 weeks to 65 years
People
60
Run by
University Hospital Tuebingen
See details and how to joinNCT05943067
Phase 2Taking people
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
Where
Berlin, Heidelberg
Age
6 months to 25 years
People
141 worldwide
Run by
Day One Biopharmaceuticals, Inc.
See details and how to joinNCT04775485 · EU 2024-510691-20-00
Phase 3Taking people
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Where
Aachen, Augsburg, Berlin, Brunswick, Chemnitz, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle (Saale), Hanover, Heidelberg, Heilbronn, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Luebeck, Magdeburg, Mannheim, Minden, Muenster, Munich, Nuernberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wolfsburg, Wuerzburg
Age
Up to 17 years
People
5,000 worldwide
Run by
Martin Schrappe
See details and how to joinNCT03643276 · EU 2023-509856-32-00
No phaseTaking people
The Sarcoma Biology and Outcome Project
Where
Heidelberg
Age
12 years and over
People
3,000
Run by
Prof. Dr. Richard F Schlenk
See details and how to joinNCT04758325
No phaseTaking people
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Where
Aachen, Bayreuth, Dresden, Mönchengladbach, München
Age
12 years and over
People
2,000 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT03818503